Federal Court upholds PMPRB jurisdiction based on “clinical similarities”
Pharma in Brief
JANUARY 15, 2024
The Federal Court ( FC ) has refused to overturn a decision of the Patented Medicine Prices Review Board ( PMPRB or Board ) that found that a patent can pertain to a medicine based on “clinical similarities” to the invention—even if the patent does not actually encompass the medicine. The patentee, Galderma Canada Inc.
Let's personalize your content